Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

Analysis of Solvency Ratios
Quarterly Data

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Solvency Ratios (Summary)

UnitedHealth Group Inc., solvency ratios (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Debt Ratios
Debt to equity
Debt to capital
Debt to assets
Financial leverage
Coverage Ratios
Interest coverage

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


Solvency ratios demonstrate a generally increasing reliance on debt financing over the observed period, though with some fluctuations. While coverage ratios initially remain strong, a clear downward trend emerges, indicating potential future challenges in meeting interest obligations.

Debt to Equity
The debt to equity ratio exhibits an increasing trend overall, rising from 0.65 in March 2022 to 0.86 in March 2025. There are quarterly variations, but the ratio generally remains above 0.70 after June 2022. A slight stabilization is observed in the latter part of the period, with values hovering around 0.84 to 0.83 from June 2024 through December 2025.
Debt to Capital
Similar to the debt to equity ratio, debt to capital shows a gradual increase, moving from 0.39 in March 2022 to 0.46 in March 2025. The ratio remains relatively stable between 0.43 and 0.46 from September 2022 through September 2025, before decreasing slightly to 0.45 in December 2025. This suggests a consistent, though moderate, increase in the proportion of debt used to finance the company’s capital structure.
Debt to Assets
The debt to assets ratio also demonstrates an upward trajectory, increasing from 0.21 in March 2022 to 0.26 in March 2025. The ratio remains relatively consistent between 0.25 and 0.26 from March 2024 through December 2025, indicating a sustained increase in the proportion of assets financed by debt.
Financial Leverage
Financial leverage, measured as total assets to equity, generally increased from 3.04 in March 2022 to 3.29 in September 2025, before stabilizing at 3.29 in December 2025. This indicates a greater use of assets relative to equity, amplifying both potential gains and losses. The ratio peaked at 3.49 in March 2023, then decreased before rising again.
Interest Coverage
The interest coverage ratio exhibits a consistent and significant downward trend. Starting at 14.26 in March 2022, it declines to 4.67 in December 2025. While initially very strong, indicating a substantial ability to cover interest expenses, the decreasing trend suggests a weakening capacity to meet these obligations from operating income. The most substantial declines occur after March 2023, with the ratio falling below 8.00 in March 2024.

In summary, the observed trends suggest a growing reliance on debt financing coupled with a diminishing ability to comfortably cover interest expenses. Continued monitoring of these ratios is warranted to assess potential risks associated with the increasing debt burden.


Debt Ratios


Coverage Ratios


Debt to Equity

UnitedHealth Group Inc., debt to equity calculation (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
 
Shareholders’ equity attributable to UnitedHealth Group
Solvency Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q4 2025 Calculation
Debt to equity = Total debt ÷ Shareholders’ equity attributable to UnitedHealth Group
= ÷ =

2 Click competitor name to see calculations.


The debt to equity ratio for the analyzed period demonstrates a generally increasing trend, with fluctuations throughout the observed timeframe. Initially, the ratio exhibited an increase from 0.65 in March 2022 to 0.71 in June 2022, followed by a slight decrease to 0.65 in September 2022. A subsequent rise to 0.74 was noted by December 2022.

A more pronounced upward trend occurred through the first half of 2023, peaking at 0.87 in March 2023. The ratio then moderated, decreasing to 0.80 in June 2023, 0.75 in September 2023, and 0.70 in December 2023. This suggests a period of debt reduction or equity growth, or a combination of both.

Recent Trends (2024-2025)
From December 2023 through December 2025, the debt to equity ratio has remained relatively stable, fluctuating between 0.83 and 0.86. The ratio increased from 0.70 in December 2023 to 0.85 in March 2024, and has remained within a narrow range since. The most recent value, 0.83 in December 2025, indicates a slight decrease from the peak observed in March 2024, but remains elevated compared to earlier periods in the analysis.

Overall, the company’s reliance on debt relative to equity has increased over the analyzed period, particularly between March 2022 and March 2023. While the ratio has stabilized in recent quarters, it remains at a higher level than observed at the beginning of the period, suggesting a shift in the company’s capital structure.

Key Observations
The most significant increase in the debt to equity ratio occurred between December 2022 and March 2023, indicating a substantial increase in debt or a decrease in equity during that period. The subsequent decline in the ratio through the remainder of 2023 suggests corrective actions were taken to manage leverage.
The consistency of the ratio between 0.83 and 0.86 from March 2024 through December 2025 suggests a deliberate effort to maintain a specific capital structure, or that offsetting changes in debt and equity are occurring.

Debt to Capital

UnitedHealth Group Inc., debt to capital calculation (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
Shareholders’ equity attributable to UnitedHealth Group
Total capital
Solvency Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q4 2025 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Click competitor name to see calculations.


The debt to capital ratio for the analyzed period demonstrates a generally increasing trend, with some quarterly fluctuations. Initially, the ratio stood at 0.39 in March 2022 and experienced a gradual increase to 0.46 by March 2024. Subsequent quarters show a slight stabilization around this level, with the ratio concluding at 0.45 in December 2025.

Overall Trend
The overall trend indicates a growing reliance on debt financing relative to capital over the observed timeframe. The ratio increased from 0.39 to 0.46 over two years, suggesting a shift in the company’s capital structure. While the increase isn’t dramatic, it warrants attention as continued increases could signal heightened financial risk.
Short-Term Fluctuations
Despite the overall upward trend, quarterly variations are present. A peak of 0.46 was observed in March 2024, June 2024, March 2025, and June 2025. These peaks are interspersed with periods of relative stability or slight decline, such as the decrease from 0.43 in September 2023 to 0.41 in December 2023. These fluctuations may be attributable to specific financing activities or changes in equity valuation during those quarters.
Recent Performance
The most recent quarters (September 2025 and December 2025) show a slight decrease in the debt to capital ratio, moving from 0.46 to 0.45. This suggests a potential stabilization or a minor reduction in debt relative to capital. However, this decrease is minimal and does not negate the overall increasing trend observed throughout the period.

The observed trend in the debt to capital ratio suggests that the company has been increasingly leveraging debt to finance its operations and growth. While not necessarily indicative of financial distress, continued monitoring of this ratio is recommended to assess the sustainability of the capital structure and potential implications for financial flexibility.


Debt to Assets

UnitedHealth Group Inc., debt to assets calculation (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
 
Total assets
Solvency Ratio
Debt to assets1
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q4 2025 Calculation
Debt to assets = Total debt ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


The debt-to-assets ratio for the analyzed period demonstrates a generally increasing trend, indicating a growing reliance on debt financing relative to the company’s asset base. Initial values were relatively stable, followed by a more pronounced increase in later periods.

Overall Trend
The debt-to-assets ratio began at 0.21 in March 2022 and generally increased to 0.25 by September 2025. This represents a 19% increase over the observed period. The most significant increases occurred between December 2022 and March 2023, and again between March 2024 and September 2024.
Short-Term Fluctuations (2022-2023)
From March 2022 to June 2022, the ratio increased from 0.21 to 0.22. A slight decrease was then observed in September 2022 (0.20), before rising to 0.23 in December 2022. The most substantial increase within this timeframe occurred between December 2022 and March 2023, with the ratio climbing to 0.25. The ratio then decreased slightly to 0.23 in June 2023, remaining relatively stable through December 2023.
Recent Stability (2024-2025)
The ratio remained consistent at 0.26 from March 2024 through December 2024. A minor decrease to 0.25 was observed in both September 2025 and December 2025, suggesting a potential stabilization or slight de-leveraging at the end of the analyzed period. However, the ratio remained elevated compared to earlier periods.
Debt and Asset Movements
Total debt increased significantly from US$47,493 million in March 2022 to US$78,389 million in December 2025, representing a 65% increase. Total assets also increased, from US$221,238 million to US$309,581 million, a 40% increase. The faster growth of debt compared to assets is the primary driver of the increasing debt-to-assets ratio.

The observed trend suggests a shift in the company’s capital structure towards greater debt financing. Continued monitoring of this ratio is recommended to assess potential risks associated with increased leverage.


Financial Leverage

UnitedHealth Group Inc., financial leverage calculation (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Total assets
Shareholders’ equity attributable to UnitedHealth Group
Solvency Ratio
Financial leverage1
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q4 2025 Calculation
Financial leverage = Total assets ÷ Shareholders’ equity attributable to UnitedHealth Group
= ÷ =

2 Click competitor name to see calculations.


Financial leverage, as indicated by the ratio of total assets to shareholders’ equity attributable to UnitedHealth Group, exhibits a generally increasing trend over the observed period, with some fluctuations. The ratio began at 3.04 in March 2022 and generally increased through December 2022, before experiencing a decrease in the first half of 2023. A subsequent increase occurred through December 2023, followed by relative stability and a slight increase into June 2025.

Initial Increase (Mar 31, 2022 – Dec 31, 2022)
From March 2022 to December 2022, the financial leverage ratio increased from 3.04 to 3.16, then to 3.26, and finally settled at 3.16. This suggests an initial increase in the proportion of assets financed by debt or other non-equity sources. The increase from September to December 2022 was minimal, indicating a potential stabilization during that period.
Mid-Term Fluctuation (Mar 31, 2023 – Dec 31, 2023)
The ratio decreased from 3.49 in March 2023 to 3.40 in June 2023, then to 3.34 in September 2023, before decreasing further to 3.08 by December 2023. This indicates a reduction in financial leverage during this period, potentially due to increased equity or decreased asset levels. The decrease is notable, suggesting a deliberate shift in the company’s capital structure or a change in asset composition.
Subsequent Stability and Slight Increase (Mar 31, 2024 – Jun 30, 2025)
From March 2024 through June 2025, the ratio experienced relative stability, fluctuating between 3.28 and 3.29. The ratio began at 3.28 in March 2024, increased to 3.20 in June 2024, then to 3.17 in September 2024, and 3.22 in December 2024. The ratio then increased to 3.26 in March 2025, 3.26 in June 2025. This suggests a period of consistent capital structure management. The slight increase in the most recent periods indicates a renewed, albeit modest, tendency towards increased financial leverage.

Overall, the observed trend suggests a dynamic approach to financial leverage. While there was an initial increase followed by a notable decrease, the ratio has largely stabilized in recent periods, with a slight upward trend in the latest reported quarters. The fluctuations warrant further investigation to understand the underlying drivers of these changes in capital structure.


Interest Coverage

UnitedHealth Group Inc., interest coverage calculation (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Net earnings (loss) attributable to UnitedHealth Group common shareholders
Add: Net income attributable to noncontrolling interest
Add: Income tax expense
Add: Interest expense
Earnings before interest and tax (EBIT)
Solvency Ratio
Interest coverage1
Benchmarks
Interest Coverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Medtronic PLC

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q4 2025 Calculation
Interest coverage = (EBITQ4 2025 + EBITQ3 2025 + EBITQ2 2025 + EBITQ1 2025) ÷ (Interest expenseQ4 2025 + Interest expenseQ3 2025 + Interest expenseQ2 2025 + Interest expenseQ1 2025)
= ( + + + ) ÷ ( + + + ) =

2 Click competitor name to see calculations.


The interest coverage ratio demonstrates a clear declining trend over the observed period. Initially strong, the ratio exhibits a consistent decrease, signaling a weakening ability to meet interest obligations from earnings before interest and tax.

Initial Period (Mar 31, 2022 – Dec 31, 2022)
The interest coverage ratio began at 14.26 and fluctuated between 13.59 and 14.66. This indicates a robust capacity to cover interest expenses with operating income during this timeframe. While some quarterly variation existed, the ratio remained consistently above 13.5, suggesting a comfortable margin of safety.
Transition Phase (Mar 31, 2023 – Dec 31, 2023)
A noticeable downward trend commenced in the subsequent period. The ratio decreased from 12.25 to 9.97, indicating a reduction in the earnings available to cover interest payments. This decline suggests increasing financial risk, although the ratio remained above 9 throughout the year.
Accelerated Decline (Mar 31, 2024 – Dec 31, 2025)
The rate of decline accelerated significantly. The ratio fell from 7.53 to 4.67 over the final two years of the observation period. This substantial decrease indicates a considerably diminished ability to service debt obligations from current earnings. The ratio’s movement below 6 suggests a heightened level of financial vulnerability. The final reported value of 4.67 represents a significant reduction from the initial values and warrants further investigation.

The concurrent increase in interest expense, while not dramatic in earlier periods, appears to contribute to the declining coverage ratio, particularly in the later quarters. The combination of decreasing EBIT and rising interest expense has created a challenging environment for maintaining a strong interest coverage position.

EBIT and Interest Expense Relationship
While EBIT experienced fluctuations, the consistent rise in interest expense, especially from March 2023 onwards, appears to be a key driver of the declining interest coverage ratio. The increasing cost of borrowing, coupled with periods of lower earnings, has progressively eroded the company’s ability to comfortably cover its interest obligations.

The observed trend suggests a growing reliance on external financing or a need to improve operational efficiency to bolster earnings and restore a more favorable interest coverage position.